$505 Million is the total value of Sio Capital Management, LLC's 89 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 122.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MESO | Buy | MESOBLAST LTDput | $29,054,000 | +297.8% | 1,563,300 | +143.8% | 5.75% | +170.0% |
| GLD | Buy | SPDR GOLD SHARES | $22,707,000 | +12.4% | 128,202 | +6.2% | 4.50% | -23.7% |
| MCK | Buy | MCKESSON CORP | $17,641,000 | +18.2% | 118,449 | +21.8% | 3.49% | -19.8% |
| JNJ | New | JOHNSON & JOHNSON | $17,032,000 | – | 114,400 | +100.0% | 3.37% | – |
| HRC | Buy | HILL-ROM HOLDINGS INC | $16,694,000 | +69.0% | 199,900 | +122.1% | 3.31% | +14.7% |
| ALBO | New | ALBIREO PHARMA INC | $15,972,000 | – | 478,624 | +100.0% | 3.16% | – |
| AMN | New | AMN HEALTHCARE SERVICES INC | $15,915,000 | – | 272,233 | +100.0% | 3.15% | – |
| ABC | Buy | AMERISOURCEBERGEN CORP | $15,882,000 | +56.8% | 163,871 | +63.0% | 3.14% | +6.4% |
| CVM | Buy | CEL-SCI CORPput | $15,245,000 | +208.8% | 1,195,700 | +261.3% | 3.02% | +109.5% |
| CAH | Buy | CARDINAL HEALTH INC | $15,140,000 | +117.3% | 322,480 | +141.6% | 3.00% | +47.5% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $14,816,000 | – | 194,744 | +100.0% | 2.93% | – |
| CI | New | CIGNA CORP | $13,793,000 | – | 81,415 | +100.0% | 2.73% | – |
| HCA | Buy | HCA HEALTHCARE INC | $13,208,000 | +66.5% | 105,932 | +29.6% | 2.62% | +13.0% |
| MOH | Buy | MOLINA HEALTHCARE INC | $12,039,000 | +19.1% | 65,774 | +15.8% | 2.38% | -19.2% |
| HZNP | New | HORIZON THERAPEUTICS PLC | $11,458,000 | – | 147,500 | +100.0% | 2.27% | – |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $10,779,000 | +104.7% | 300,094 | +141.6% | 2.13% | +38.9% |
| MCRB | Buy | SERES THERAPEUTICS INCput | $8,969,000 | +3297.3% | 316,800 | +470.8% | 1.78% | +2206.5% |
| DGX | New | QUEST DIAGNOSTICS INC | $8,587,000 | – | 75,000 | +100.0% | 1.70% | – |
| RDUS | Buy | RADIUS HEALTH INC | $7,879,000 | +59.5% | 694,770 | +91.7% | 1.56% | +8.2% |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $7,778,000 | – | 206,638 | +100.0% | 1.54% | – |
| ITGR | New | INTEGER HOLDINGS CORP | $7,634,000 | – | 129,376 | +100.0% | 1.51% | – |
| VRAY | Buy | VIEWRAY INC | $7,134,000 | +146.0% | 2,038,175 | +57.4% | 1.41% | +67.0% |
| OFIX | Buy | ORTHOFIX MEDICAL INC | $6,786,000 | +10.5% | 217,917 | +13.6% | 1.34% | -25.0% |
| SYNH | New | SYNEOS HEALTH INCcl a | $5,916,000 | – | 111,285 | +100.0% | 1.17% | – |
| CRIS | Buy | CURIS INC | $5,792,000 | +11.3% | 4,950,051 | +15.1% | 1.15% | -24.4% |
| KOD | Buy | KODIAK SCIENCES INC | $5,456,000 | +389.3% | 92,150 | +347.4% | 1.08% | +232.3% |
| CSII | New | CARDIOVASCULAR SYSTEMS INC | $4,911,000 | – | 124,808 | +100.0% | 0.97% | – |
| EPIX | New | ESSA PHARMA INC | $4,527,000 | – | 656,043 | +100.0% | 0.90% | – |
| HLF | New | HERBALIFE NUTRITION LTD | $4,133,000 | – | 88,600 | +100.0% | 0.82% | – |
| MDT | New | MEDTRONIC PLC | $4,053,000 | – | 39,000 | +100.0% | 0.80% | – |
| ARDX | Buy | ARDELYX INC | $3,960,000 | -4.9% | 754,321 | +25.4% | 0.78% | -35.5% |
| BDX | New | BECTON DICKINSON AND CO | $3,856,000 | – | 16,573 | +100.0% | 0.76% | – |
| RDNT | Buy | RADNET INC | $3,432,000 | +59.9% | 223,561 | +65.3% | 0.68% | +8.6% |
| ANIK | Buy | ANIKA THERAPEUTICS INC | $3,330,000 | +145.0% | 94,102 | +161.2% | 0.66% | +66.0% |
| HSAQ | New | HEALTH SCIENCES ACQUISITIONS CORPORATION 2 | $2,750,000 | – | 250,000 | +100.0% | 0.54% | – |
| CCRN | New | CROSS COUNTRY HEALTHCARE INC | $2,604,000 | – | 401,235 | +100.0% | 0.52% | – |
| CERC | Buy | CERECOR INC | $2,345,000 | -9.8% | 1,030,776 | +3.1% | 0.46% | -38.9% |
| NBSE | Buy | NEUBASE THERAPEUTICS INC | $2,310,000 | +46.7% | 304,376 | +69.7% | 0.46% | -0.7% |
| OYST | New | OYSTER POINT PHARMA INC | $2,234,000 | – | 105,803 | +100.0% | 0.44% | – |
| DTIL | Buy | PRECISION BIOSCIENCES INC | $2,193,000 | +42.3% | 355,963 | +92.4% | 0.43% | -3.6% |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $2,021,000 | +22.6% | 209,205 | +45.2% | 0.40% | -16.8% |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $1,960,000 | – | 56,000 | +100.0% | 0.39% | – |
| AYLA | Buy | AYALA PHARMACEUTICALS INC | $1,843,000 | +59.3% | 159,966 | +39.7% | 0.36% | +8.0% |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $1,832,000 | – | 189,062 | +100.0% | 0.36% | – |
| ODT | New | ODONATE THERAPEUTICS INC | $1,813,000 | – | 135,000 | +100.0% | 0.36% | – |
| NTUS | New | NATUS MEDICAL INC | $1,779,000 | – | 103,825 | +100.0% | 0.35% | – |
| CLRB | Buy | CELLECTAR BIOSCIENCES INC | $1,692,000 | +596.3% | 1,364,457 | +620.2% | 0.34% | +371.8% |
| VREX | New | VAREX IMAGING CORP | $1,468,000 | – | 115,394 | +100.0% | 0.29% | – |
| MEIP | Buy | MEI PHARMA INC | $1,398,000 | +606.1% | 448,047 | +832.5% | 0.28% | +377.6% |
| BCEL | Buy | ATRECA INC | $1,100,000 | +140.2% | 78,768 | +266.0% | 0.22% | +62.7% |
| CRBP | New | CORBUS PHARMACEUTICALS HOLDINGS INCput | $1,001,000 | – | 556,000 | +100.0% | 0.20% | – |
| AHACU | New | ALPHA HEALTHCARE ACQUISITION CORPunit 09/21/2027 | $992,000 | – | 100,000 | +100.0% | 0.20% | – |
| ZSAN | New | ZOSANO PHARMA CORP | $733,000 | – | 452,542 | +100.0% | 0.14% | – |
| DFHTU | New | DEERFIELD HEALTHCARE TECHNOLOGY ACQUISITIONS CORPunit 07/16/2025 | $532,000 | – | 50,000 | +100.0% | 0.10% | – |
| CASI | New | CASI PHARMACEUTICALS INC | $344,000 | – | 225,000 | +100.0% | 0.07% | – |
| PANAU | New | PANACEA ACQUISITION CORPunit | $180,000 | – | 15,000 | +100.0% | 0.04% | – |
| MYOV | New | MYOVANT SCIENCES LTD | $142,000 | – | 10,100 | +100.0% | 0.03% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $71,000 | – | 4,796 | +100.0% | 0.01% | – |
| GDRX | New | GOODRX HOLDINGS INC | $56,000 | – | 1,000 | +100.0% | 0.01% | – |
| PMVP | New | PMV PHARMACEUTICALS INC | $36,000 | – | 1,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.